GSA Capital Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,732
| Closed | -$695K | – | 2222 |
|
|
2025
Q4 | $695K | Buy |
+7,732
| New | +$733K | 0.06% | 596 |
|
|
2024
Q3 | – | Sell |
-2,140
| Closed | -$232K | – | 2074 |
|
|
2024
Q2 | $232K | Buy |
+2,140
| New | +$252K | 0.02% | 1405 |
|
|
2023
Q2 | – | Sell |
-4,799
| Closed | -$620K | – | 2001 |
|
|
2023
Q1 | $620K | Buy |
+4,799
| New | +$603K | 0.06% | 576 |
|
|
2022
Q1 | – | Sell |
-3,636
| Closed | -$448K | – | 1906 |
|
|
2021
Q4 | $448K | Buy |
+3,636
| New | +$476K | 0.06% | 670 |
|
|
2020
Q2 | – | Sell |
-2,505
| Closed | -$246K | – | 1174 |
|
|
2020
Q1 | $246K | Sell |
2,505
-9,835
| -80% | -$1.29M | 0.06% | 622 |
|
|
2019
Q4 | $1.79M | Buy |
12,340
+7,558
| +158% | +$1.04M | 0.21% | 39 |
|
|
2019
Q3 | $637K | Sell |
4,782
-7,728
| -62% | -$998K | 0.09% | 402 |
|
|
2019
Q2 | $1.43M | Buy |
+12,510
| New | +$1.47M | 0.16% | 106 |
|
|
2019
Q1 | – | Sell |
-5,943
| Closed | -$598K | – | 1736 |
|
|
2018
Q4 | $598K | Buy |
+5,943
| New | +$668K | 0.07% | 464 |
|
|
2018
Q2 | – | Sell |
-16,667
| Closed | -$1.76M | – | 1973 |
|
|
2018
Q1 | $1.76M | Buy |
+16,667
| New | +$1.94M | 0.09% | 348 |
|
|
2016
Q1 | – | Sell |
-6,328
| Closed | -$630K | – | 1953 |
|
|
2015
Q4 | $630K | Sell |
6,328
-10,383
| -62% | -$1.02M | 0.03% | 1008 |
|
|
2015
Q3 | $1.52M | Sell |
16,711
-20,393
| -55% | -$2.04M | 0.07% | 389 |
|
|
2015
Q2 | $3.94M | Buy |
37,104
+17,258
| +87% | +$1.91M | 0.15% | 94 |
|
|
2015
Q1 | $2.26M | Buy |
19,846
+5,245
| +36% | +$598K | 0.09% | 275 |
|
|
2014
Q4 | $1.61M | Buy |
14,601
+4,513
| +45% | +$476K | 0.11% | 214 |
|
|
2014
Q3 | $985K | Sell |
10,088
-20,800
| -67% | -$2.05M | 0.05% | 504 |
|
|
2014
Q2 | $3.12M | Sell |
30,888
-21,848
| -41% | -$2.13M | 0.14% | 126 |
|
|
2014
Q1 | $4.84M | Buy |
52,736
+40,453
| +329% | +$3.73M | 0.34% | 45 |
|
|
2013
Q4 | $1.11M | Buy |
12,283
+1,880
| +18% | +$163K | 0.09% | 301 |
|
|
2013
Q3 | $830K | Sell |
10,403
-9,961
| -49% | -$784K | 0.07% | 460 |
|
|
2013
Q2 | $1.48M | Buy |
+20,364
| New | +$1.52M | 0.18% | 115 |
|
Other funds holding ZBH
GSA Capital Partners's ZBH Position: Q1 2026 in Review
GSA Capital Partners sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 7,732 shares — an estimated $695K sold.
GSA Capital Partners first reported a position in ZBH in Q2 2013 and held it in 21 quarters. The position peaked at $4.84M in Q1 2014. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- GSA Capital Partners reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 7,732 Zimmer Biomet shares in Q1 2026, an estimated $695K.
- GSA Capital Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 21 quarters.
- GSA Capital Partners's Zimmer Biomet position peaked at $4.84M in Q1 2014.
- 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.